Project Grant R03DE033467
Award Date
8/1/24
Completion Date
7/31/26
Dollars Obligated
$339K
Federal Agency
National Institute of Dental and Craniofacial Research
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $608,632.33 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Research Foundation For The State University Of New York (RF SUNY). The award, effective September 1, 2024, supports a research project investigating the role of rare chemosensory epithelial cells known as "tuft cells" in salivary gland immunity. The project aims to utilize advanced microscopic techniques,...
The federal Project Grant award of $1,403,398 was granted on September 2, 2024 by the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121). The award supports research aimed at utilizing advanced imaging approaches to develop imaging-based biomarkers related to the hybrid epithelial/mesenchymal state (HEM) and its interactions with the immune system in head and neck squamous cell carcinoma (HNSCC)....
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), focuses on understanding the role of CD4+ memory T cell subtypes in periodontal disease recurrence. The $248,999 award, with a project period from Apr 1, 2025 to Mar 31, 2030, aims to: Identify the spatiotemporal development of CD4+ memory T cells in periodontal tissues to determine their roles in the gingival immune landscape....
This Project Grant award, totaling $390,000.00, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) federal grant program. The primary objective is to leverage single-cell co-culture and gene expression profiling to identify tumor antigen-specific T cells in oral squamous cell carcinoma (OSCC). Key products and services to be delivered include: Optimizing a high-throughput, single-cell co-culture system...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $1 Project Grant to the Mayo Clinic under the Oral Diseases and Disorders Research (CFDA 93.121) program. The grant, titled "COMMON FUND GENE UTILITY COMPENDIUM: A SYSTEMS BIOLOGY RESOURCE TO EXPLORE TISSUE-SPECIFIC FUNCTIONAL GENES AND DRUGGABLE GENOMES," aims to leverage NIH Common Fund datasets to identify tissue-specific druggable functional genes (TS-DFGs) that play critical roles in diseases like liver...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $226,500 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Medical University of South Carolina. The grant, titled "CD38 Signaling in Aging-Associated Immune Responses Induced by Oral Pathogens," aims to define how oral pathogens affect aging-associated immune responses and determine if inhibition of the CD38 enzyme can alleviate inflammatory bone loss and...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a Project Grant (CFDA 93.121 - Oral Diseases and Disorders Research) in the amount of $473,632 to the University of Toledo on May 1, 2025. The purpose of this 3-year project is to investigate the role of megakaryocytes (MEGs) and their response to the cytokine interleukin-17 (IL-17) in oral mucosal immunity, particularly during oropharyngeal candidiasis caused by Candida albicans. The research aims to elucidate the...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $628,965 to the Icahn School of Medicine at Mount Sinai to conduct research on immune-derived mediators that regulate salivary gland development and differentiation. The 5-year project aims to elucidate how immune cells, particularly tissue-resident macrophages, govern salivary gland epithelial cell processes and...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the CFDA Program 93.121 Oral Diseases and Disorders Research, provides $401,500.00 to Louisiana State University Health Sciences Center-Shreveport to investigate fundamental aspects of the innate immune response to SARS-CoV-2 within the salivary gland. The key objectives are to explore how antigen presentation mechanisms may shape or reflect local immune activity in this tissue, in order to...
This Project Grant award of $274,100, provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), will fund research to investigate the impact of oral cancer on the trafficking and signaling of the protease-activated receptor 2 (PAR2) in trigeminal neurons. The goal is to develop location-selective nanoparticle drug delivery systems to alleviate oral cancer pain. The research will be conducted at New York...